These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 9646225)

  • 41. [Reversible ageusia and hyposmia induced by interferon in a patient with chronic hepatitis C].
    Irigoien Aleixandre S; Castiella Eguzkira A; Fernández Fernández FJ
    Rev Esp Enferm Dig; 2003 May; 95(5):364-8. PubMed ID: 12828524
    [No Abstract]   [Full Text] [Related]  

  • 42. HCV genotypes and breakthrough in patients treated with recombinant alpha interferon.
    Roffi L; Colloredo G; Brugnetti B; Bellati G; Ricci A; Scalori A; Antonelli G; Panizzuti F; Pozzi M; Pioltelli P; Mancia G
    Am J Gastroenterol; 1998 Sep; 93(9):1602-3. PubMed ID: 9732970
    [No Abstract]   [Full Text] [Related]  

  • 43. Clinical outcome of chronic hepatitis C in patients treated with interferon: comparison between responders and non-responders.
    Morisco F; Marmo R; Iasevoli P; Sessa G; Tuccillo C; Del Vecchio Blanco C; Caporaso N
    Ital J Gastroenterol Hepatol; 1999; 31(6):454-8. PubMed ID: 10575561
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-term outcome of chronic hepatitis C treated with interferon.
    Hadziyannis SJ; Papatheodoridis GV
    Ital J Gastroenterol Hepatol; 1999; 31(6):459-61. PubMed ID: 10575562
    [No Abstract]   [Full Text] [Related]  

  • 45. Improving anti-HCV therapy.
    Pol S; Mallet VO
    Discov Med; 2006 Oct; 6(35):187-90. PubMed ID: 17234140
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chronic hepatitis C in the human immunodeficiency virus-infected patient: management strategies.
    Bhattacharya D; Imperial JC; Keeffe EB
    Clin Gastroenterol Hepatol; 2006 Mar; 4(3):288-92. PubMed ID: 16527689
    [No Abstract]   [Full Text] [Related]  

  • 47. [Treatment of hepatitis C virus-related cirrhosis].
    Bronowicki JP
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B220-4. PubMed ID: 12180292
    [No Abstract]   [Full Text] [Related]  

  • 48. Management of cirrhosis due to chronic hepatitis C.
    Everson GT
    J Hepatol; 2005; 42 Suppl(1):S65-74. PubMed ID: 15777574
    [No Abstract]   [Full Text] [Related]  

  • 49. Hepatitis C virus antiviral therapy in patients with cirrhosis.
    Arenas JI; Vargas HE
    Gastroenterol Clin North Am; 2004 Sep; 33(3):549-62, ix. PubMed ID: 15324943
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Interferon therapy in chronic viral hepatitis; an autoimmunity dilemma].
    Gutkowski K; Gutkowska D; Bilkiewicz T
    Przegl Lek; 2007; 64(3):148-52. PubMed ID: 17941466
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Histological and nonhistological criteria in the evaluation of liver involvement in chronic hepatitis C.
    Mateescu RB; Rimbaş M; Stăniceanu F; Zurac S; Dragomir P; Voiosu MR; Tătaru M; Zota M; Bucurică S
    Rom J Intern Med; 2006; 44(2):117-30. PubMed ID: 17236293
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Treatment of chronic hepatitis C and alcohol consumption].
    Mathurin P; Canva V; Dharancy S; Paris JC
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B248-51. PubMed ID: 12180297
    [No Abstract]   [Full Text] [Related]  

  • 53. Pulmonary hypertension and hepatitis C virus related cirrhosis.
    Perrone C; Paroli M; Morelli S
    Ital J Gastroenterol Hepatol; 1997 Jun; 29(3):283-4. PubMed ID: 9646225
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.